APO Research
Talk to an analyst

APO RESEARCH · REPORT

Transconjunctival Sutureless Vitrectomy (TSV)

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Transconjunctival Sutureless Vitrectomy (TSV) Market Analysis and Forecast 2026-2032

4 June 2026213 pages

Choose your research edition.

Industry ResearchTransconjunctival Sutureless Vitrectomy (TSV) Industry Research Report 2026119 pages · $2,950 USDIndustry Growth & TrendsGlobal Transconjunctival Sutureless Vitrectomy (TSV) Industry Growth and Trends Forecast to 203285 pages · $3,450 USDMarket StructureGlobal Transconjunctival Sutureless Vitrectomy (TSV) Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032189 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Transconjunctival Sutureless Vitrectomy (TSV) Market Outlook and Growth Opportunities 2026191 pages · $4,250 USDMarket Analysis & ForecastGlobal Transconjunctival Sutureless Vitrectomy (TSV) Market Analysis and Forecast 2026-2032213 pages · $4,950 USD

Market perspective

The global Transconjunctival Sutureless Vitrectomy (TSV) market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Transconjunctival Sutureless Vitrectomy (TSV) is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Transconjunctival Sutureless Vitrectomy (TSV) is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Transconjunctival Sutureless Vitrectomy (TSV) is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Transconjunctival Sutureless Vitrectomy (TSV) is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Transconjunctival Sutureless Vitrectomy (TSV) include Bascom Palmer Eye Institute, Moorfields Eye Hospital, Massachusetts Eye and Ear Infirmary, Sichuan Provincial People's Hospital, Tongji Hospital Affiliated to Tongji University and Tianjin Medical University Eye Hospital, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Transconjunctival Sutureless Vitrectomy (TSV), market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Transconjunctival Sutureless Vitrectomy (TSV), also provides the revenue of main regions and countries. Of the upcoming market potential for Transconjunctival Sutureless Vitrectomy (TSV), and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Transconjunctival Sutureless Vitrectomy (TSV) revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Transconjunctival Sutureless Vitrectomy (TSV) market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Transconjunctival Sutureless Vitrectomy (TSV) revenue, projected growth trends, production technology, application and end-user industry.

Transconjunctival Sutureless Vitrectomy (TSV) Segment by Company

Bascom Palmer Eye Institute

Moorfields Eye Hospital

Massachusetts Eye and Ear Infirmary

Sichuan Provincial People's Hospital

Tongji Hospital Affiliated to Tongji University

Tianjin Medical University Eye Hospital

Transconjunctival Sutureless Vitrectomy (TSV) Segment by Type

25G

23G

Transconjunctival Sutureless Vitrectomy (TSV) Segment by Application

Ophthalmology

Others

Transconjunctival Sutureless Vitrectomy (TSV) Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Transconjunctival Sutureless Vitrectomy (TSV) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Transconjunctival Sutureless Vitrectomy (TSV) and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Transconjunctival Sutureless Vitrectomy (TSV).

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Transconjunctival Sutureless Vitrectomy (TSV) in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Transconjunctival Sutureless Vitrectomy (TSV) company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Transconjunctival Sutureless Vitrectomy (TSV) revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Transconjunctival Sutureless Vitrectomy (TSV) Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. 25G Major Player Table 3. 23G Major Player Table 4. Global Transconjunctival Sutureless Vitrectomy (TSV) Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Ophthalmology Major Player Table 6. Others Major Player Table 7. Transconjunctival Sutureless Vitrectomy (TSV) Industry Trends Table 8. Transconjunctival Sutureless Vitrectomy (TSV) Industry Drivers Table 9. Transconjunctival Sutureless Vitrectomy (TSV) Industry Opportunities and Challenges Table 10. Transconjunctival Sutureless Vitrectomy (TSV) Industry Restraints Table 11. Global Transconjunctival Sutureless Vitrectomy (TSV) Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 12. Global Transconjunctival Sutureless Vitrectomy (TSV) Market Size by Region (2021-2026) & (US$ Million) Table 13. Global Transconjunctival Sutureless Vitrectomy (TSV) Market Share by Region (2021-2026) Table 14. Global Transconjunctival Sutureless Vitrectomy (TSV) Market Size by Region (2027-2032) & (US$ Million) Table 15. Global Transconjunctival Sutureless Vitrectomy (TSV) Market Share by Region (2027-2032) Table 16. Global Transconjunctival Sutureless Vitrectomy (TSV) Revenue by Players (US$ Million) & (2021-2026) Table 17. Global Transconjunctival Sutureless Vitrectomy (TSV) Revenue Market Share by Players (2021-2026) Table 18. Global Transconjunctival Sutureless Vitrectomy (TSV) Key Players Ranking, 2024 VS 2025 VS 2026 Table 19. Global Transconjunctival Sutureless Vitrectomy (TSV) Key Players Headquarters & Area Served Table 20. Global Transconjunctival Sutureless Vitrectomy (TSV) Players, Product Type & Application Table 21. Global Transconjunctival Sutureless Vitrectomy (TSV) Players Establishment Date Table 22. Global Players Market Concentration Ratio (CR5 and HHI) Table 23. Global Transconjunctival Sutureless Vitrectomy (TSV) by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 24. Global Transconjunctival Sutureless Vitrectomy (TSV) Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Transconjunctival Sutureless Vitrectomy (TSV) Revenue by Type (2021-2026) & (US$ Million) Table 26. Global Transconjunctival Sutureless Vitrectomy (TSV) Revenue by Type (2027-2032) & (US$ Million) Table 27. Global Transconjunctival Sutureless Vitrectomy (TSV) Revenue Market Share by Type (2021-2026) Table 28. Global Transconjunctival Sutureless Vitrectomy (TSV) Revenue Market Share by Type (2027-2032) Table 29. Global Transconjunctival Sutureless Vitrectomy (TSV) Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 30. Global Transconjunctival Sutureless Vitrectomy (TSV) Revenue by Application (2021-2026) & (US$ Million) Table 31. Global Transconjunctival Sutureless Vitrectomy (TSV) Revenue by Application (2027-2032) & (US$ Million) Table 32. Global Transconjunctival Sutureless Vitrectomy (TSV) Revenue Market Share by Application (2021-2026) Table 33. Global Transconjunctival Sutureless Vitrectomy (TSV) Revenue Market Share by Application (2027-2032) Table 34. Bascom Palmer Eye Institute Company Information Table 35. Bascom Palmer Eye Institute Business Overview Table 36. Bascom Palmer Eye Institute Transconjunctival Sutureless Vitrectomy (TSV) Revenue and Gross Margin (US$ Million) & (2021-2026) Table 37. Bascom Palmer Eye Institute Transconjunctival Sutureless Vitrectomy (TSV) Product Portfolio Table 38. Bascom Palmer Eye Institute Recent Development Table 39. Moorfields Eye Hospital Company Information Table 40. Moorfields Eye Hospital Business Overview Table 41. Moorfields Eye Hospital Transconjunctival Sutureless Vitrectomy (TSV) Revenue and Gross Margin (US$ Million) & (2021-2026) Table 42. Moorfields Eye Hospital Transconjunctival Sutureless Vitrectomy (TSV) Product Portfolio Table 43. Moorfields Eye Hospital Recent Development Table 44. Massachusetts Eye and Ear Infirmary Company Information Table 45. Massachusetts Eye and Ear Infirmary Business Overview Table 46. Massachusetts Eye and Ear Infirmary Transconjunctival Sutureless Vitrectomy (TSV) Revenue and Gross Margin (US$ Million) & (2021-2026) Table 47. Massachusetts Eye and Ear Infirmary Transconjunctival Sutureless Vitrectomy (TSV) Product Portfolio Table 48. Massachusetts Eye and Ear Infirmary Recent Development Table 49. Sichuan Provincial People's Hospital Company Information Table 50. Sichuan Provincial People's Hospital Business Overview Table 51. Sichuan Provincial People's Hospital Transconjunctival Sutureless Vitrectomy (TSV) Revenue and Gross Margin (US$ Million) & (2021-2026) Table 52. Sichuan Provincial People's Hospital Transconjunctival Sutureless Vitrectomy (TSV) Product Portfolio Table 53. Sichuan Provincial People's Hospital Recent Development Table 54. Tongji Hospital Affiliated to Tongji University Company Information Table 55. Tongji Hospital Affiliated to Tongji University Business Overview Table 56. Tongji Hospital Affiliated to Tongji University Transconjunctival Sutureless Vitrectomy (TSV) Revenue and Gross Margin (US$ Million) & (2021-2026) Table 57. Tongji Hospital Affiliated to Tongji University Transconjunctival Sutureless Vitrectomy (TSV) Product Portfolio Table 58. Tongji Hospital Affiliated to Tongji University Recent Development Table 59. Tianjin Medical University Eye Hospital Company Information Table 60. Tianjin Medical University Eye Hospital Business Overview Table 61. Tianjin Medical University Eye Hospital Transconjunctival Sutureless Vitrectomy (TSV) Revenue and Gross Margin (US$ Million) & (2021-2026) Table 62. Tianjin Medical University Eye Hospital Transconjunctival Sutureless Vitrectomy (TSV) Product Portfolio Table 63. Tianjin Medical University Eye Hospital Recent Development Table 64. North America Transconjunctival Sutureless Vitrectomy (TSV) Revenue by Type (2021-2026) & (US$ Million) Table 65. North America Transconjunctival Sutureless Vitrectomy (TSV) Revenue by Type (2027-2032) & (US$ Million) Table 66. North America Transconjunctival Sutureless Vitrectomy (TSV) Revenue by Application (2021-2026) & (US$ Million) Table 67. North America Transconjunctival Sutureless Vitrectomy (TSV) Revenue by Application (2027-2032) & (US$ Million) Table 68. North America Transconjunctival Sutureless Vitrectomy (TSV) Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 69. North America Transconjunctival Sutureless Vitrectomy (TSV) Revenue by Country (2021-2026) & (US$ Million) Table 70. North America Transconjunctival Sutureless Vitrectomy (TSV) Revenue by Country (US$ Million) & (2027-2032) Table 71. Europe Transconjunctival Sutureless Vitrectomy (TSV) Revenue by Type (2021-2026) & (US$ Million) Table 72. Europe Transconjunctival Sutureless Vitrectomy (TSV) Revenue by Type (2027-2032) & (US$ Million) Table 73. Europe Transconjunctival Sutureless Vitrectomy (TSV) Revenue by Application (2021-2026) & (US$ Million) Table 74. Europe Transconjunctival Sutureless Vitrectomy (TSV) Revenue by Application (2027-2032) & (US$ Million) Table 75. Europe Transconjunctival Sutureless Vitrectomy (TSV) Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 76. Europe Transconjunctival Sutureless Vitrectomy (TSV) Revenue by Country (2021-2026) & (US$ Million) Table 77. Europe Transconjunctival Sutureless Vitrectomy (TSV) Revenue by Country (US$ Million) & (2027-2032) Table 78. China Transconjunctival Sutureless Vitrectomy (TSV) Revenue by Type (2021-2026) & (US$ Million) Table 79. China Transconjunctival Sutureless Vitrectomy (TSV) Revenue by Type (2027-2032) & (US$ Million) Table 80. China Transconjunctival Sutureless Vitrectomy (TSV) Revenue by Application (2021-2026) & (US$ Million) Table 81. China Transconjunctival Sutureless Vitrectomy (TSV) Revenue by Application (2027-2032) & (US$ Million) Table 82. Asia Transconjunctival Sutureless Vitrectomy (TSV) Revenue by Type (2021-2026) & (US$ Million) Table 83. Asia Transconjunctival Sutureless Vitrectomy (TSV) Revenue by Type (2027-2032) & (US$ Million) Table 84. Asia Transconjunctival Sutureless Vitrectomy (TSV) Revenue by Application (2021-2026) & (US$ Million) Table 85. Asia Transconjunctival Sutureless Vitrectomy (TSV) Revenue by Application (2027-2032) & (US$ Million) Table 86. Asia Transconjunctival Sutureless Vitrectomy (TSV) Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 87. Asia Transconjunctival Sutureless Vitrectomy (TSV) Revenue by Region (US$ Million) & (2021-2026) Table 88. Asia Transconjunctival Sutureless Vitrectomy (TSV) Revenue by Region (US$ Million) & (2027-2032) Table 89. SAMEA Transconjunctival Sutureless Vitrectomy (TSV) Revenue by Type (2021-2026) & (US$ Million) Table 90. SAMEA Transconjunctival Sutureless Vitrectomy (TSV) Revenue by Type (2027-2032) & (US$ Million) Table 91. SAMEA Transconjunctival Sutureless Vitrectomy (TSV) Revenue by Application (2021-2026) & (US$ Million) Table 92. SAMEA Transconjunctival Sutureless Vitrectomy (TSV) Revenue by Application (2027-2032) & (US$ Million) Table 93. SAMEA Transconjunctival Sutureless Vitrectomy (TSV) Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 94. SAMEA Transconjunctival Sutureless Vitrectomy (TSV) Revenue by Country (2021-2026) & (US$ Million) Table 95. SAMEA Transconjunctival Sutureless Vitrectomy (TSV) Revenue by Country (US$ Million) & (2027-2032) Table 96. Research Programs/Design for This Report Table 97. Authors List of This Report Table 98. Secondary Sources Table 99. Primary Sources List of Figures Figure 1. Transconjunctival Sutureless Vitrectomy (TSV) Image Figure 2. Global Transconjunctival Sutureless Vitrectomy (TSV) Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Transconjunctival Sutureless Vitrectomy (TSV) Market Size Share 2021 VS 2025 VS 2032 Figure 4. 25G Image Figure 5. 23G Image Figure 6. Global Transconjunctival Sutureless Vitrectomy (TSV) Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Transconjunctival Sutureless Vitrectomy (TSV) Market Size Share 2021 VS 2025 VS 2032 Figure 8. Ophthalmology Image Figure 9. Others Image Figure 10. Global Transconjunctival Sutureless Vitrectomy (TSV) Market Size (US$ Million) & (2021-2032) Figure 11. Global Transconjunctival Sutureless Vitrectomy (TSV) Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 12. Global Transconjunctival Sutureless Vitrectomy (TSV) Market Share by Region: 2021 VS 2025 VS 2032 Figure 13. Global Transconjunctival Sutureless Vitrectomy (TSV) Players Revenue Share Top 10 and Top 5 in 2025 Figure 14. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 15. Global Transconjunctival Sutureless Vitrectomy (TSV) Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global Transconjunctival Sutureless Vitrectomy (TSV) Revenue Market Share 2021 VS 2025 VS 2032 Figure 17. Global Transconjunctival Sutureless Vitrectomy (TSV) Revenue Market Share by Type (2021-2032) Figure 18. Global Transconjunctival Sutureless Vitrectomy (TSV) Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 19. Global Transconjunctival Sutureless Vitrectomy (TSV) Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 20. Global Transconjunctival Sutureless Vitrectomy (TSV) Revenue Market Share by Application (2021-2032) Figure 21. North America Transconjunctival Sutureless Vitrectomy (TSV) Revenue YoY Growth (2021-2032) & (US$ Million) Figure 22. North America Transconjunctival Sutureless Vitrectomy (TSV) Revenue Share by Type (2021-2032) Figure 23. North America Transconjunctival Sutureless Vitrectomy (TSV) Revenue Share by Application (2021-2032) Figure 24. North America Transconjunctival Sutureless Vitrectomy (TSV) Revenue Share by Country (2021-2032) Figure 25. United States Transconjunctival Sutureless Vitrectomy (TSV) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 26. Canada Transconjunctival Sutureless Vitrectomy (TSV) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 27. Mexico Transconjunctival Sutureless Vitrectomy (TSV) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 28. Europe Transconjunctival Sutureless Vitrectomy (TSV) Revenue YoY Growth (2021-2032) & (US$ Million) Figure 29. Europe Transconjunctival Sutureless Vitrectomy (TSV) Revenue Share by Type (2021-2032) Figure 30. Europe Transconjunctival Sutureless Vitrectomy (TSV) Revenue Share by Application (2021-2032) Figure 31. Europe Transconjunctival Sutureless Vitrectomy (TSV) Revenue Share by Country (2021-2032) Figure 32. Germany Transconjunctival Sutureless Vitrectomy (TSV) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 33. France Transconjunctival Sutureless Vitrectomy (TSV) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 34. U.K. Transconjunctival Sutureless Vitrectomy (TSV) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 35. Italy Transconjunctival Sutureless Vitrectomy (TSV) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. Spain Transconjunctival Sutureless Vitrectomy (TSV) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. Russia Transconjunctival Sutureless Vitrectomy (TSV) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Netherlands Transconjunctival Sutureless Vitrectomy (TSV) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Nordic Countries Transconjunctival Sutureless Vitrectomy (TSV) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. China Transconjunctival Sutureless Vitrectomy (TSV) Revenue YoY Growth (2021-2032) & (US$ Million) Figure 41. China Transconjunctival Sutureless Vitrectomy (TSV) Revenue Share by Type (2021-2032) Figure 42. China Transconjunctival Sutureless Vitrectomy (TSV) Revenue Share by Application (2021-2032) Figure 43. Asia Transconjunctival Sutureless Vitrectomy (TSV) Revenue YoY Growth (2021-2032) & (US$ Million) Figure 44. Asia Transconjunctival Sutureless Vitrectomy (TSV) Revenue Share by Type (2021-2032) Figure 45. Asia Transconjunctival Sutureless Vitrectomy (TSV) Revenue Share by Application (2021-2032) Figure 46. Asia Transconjunctival Sutureless Vitrectomy (TSV) Revenue Share by Region (2021-2032) Figure 47. Japan Transconjunctival Sutureless Vitrectomy (TSV) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 48. South Korea Transconjunctival Sutureless Vitrectomy (TSV) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 49. India Transconjunctival Sutureless Vitrectomy (TSV) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 50. Australia Transconjunctival Sutureless Vitrectomy (TSV) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. Taiwan Transconjunctival Sutureless Vitrectomy (TSV) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. Southeast Asia Transconjunctival Sutureless Vitrectomy (TSV) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. SAMEA Transconjunctival Sutureless Vitrectomy (TSV) Revenue YoY Growth (2021-2032) & (US$ Million) Figure 54. SAMEA Transconjunctival Sutureless Vitrectomy (TSV) Revenue Share by Type (2021-2032) Figure 55. SAMEA Transconjunctival Sutureless Vitrectomy (TSV) Revenue Share by Application (2021-2032) Figure 56. SAMEA Transconjunctival Sutureless Vitrectomy (TSV) Revenue Share by Country (2021-2032) Figure 57. Brazil Transconjunctival Sutureless Vitrectomy (TSV) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 58. Argentina Transconjunctival Sutureless Vitrectomy (TSV) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 59. Chile Transconjunctival Sutureless Vitrectomy (TSV) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 60. Colombia Transconjunctival Sutureless Vitrectomy (TSV) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Peru Transconjunctival Sutureless Vitrectomy (TSV) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Saudi Arabia Transconjunctival Sutureless Vitrectomy (TSV) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Israel Transconjunctival Sutureless Vitrectomy (TSV) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. UAE Transconjunctival Sutureless Vitrectomy (TSV) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Turkey Transconjunctival Sutureless Vitrectomy (TSV) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Iran Transconjunctival Sutureless Vitrectomy (TSV) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Egypt Transconjunctival Sutureless Vitrectomy (TSV) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Years Considered Figure 69. Research Process Figure 70. Key Executives Interviewed

Scope & coverage.

Types
  • 25G
  • 23G
Applications
  • Ophthalmology
  • Others
Companies covered
  • Bascom Palmer Eye Institute
  • Moorfields Eye Hospital
  • Massachusetts Eye and Ear Infirmary
  • Sichuan Provincial People's Hospital
  • Tongji Hospital Affiliated to Tongji University
  • Tianjin Medical University Eye Hospital

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Transconjunctival Sutureless Vitrectomy (TSV) Market by Type
  3. 1.2.1 Global Transconjunctival Sutureless Vitrectomy (TSV) Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 25G
  5. 1.2.3 23G
  6. 1.3 Transconjunctival Sutureless Vitrectomy (TSV) Market by Application
  7. 1.3.1 Global Transconjunctival Sutureless Vitrectomy (TSV) Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Ophthalmology
  9. 1.3.3 Others
  10. 1.4 Assumptions and Limitations
  11. 1.5 Study Goals and Objectives
2 Transconjunctival Sutureless Vitrectomy (TSV) Market Dynamics
  1. 2.1 Transconjunctival Sutureless Vitrectomy (TSV) Industry Trends
  2. 2.2 Transconjunctival Sutureless Vitrectomy (TSV) Industry Drivers
  3. 2.3 Transconjunctival Sutureless Vitrectomy (TSV) Industry Opportunities and Challenges
  4. 2.4 Transconjunctival Sutureless Vitrectomy (TSV) Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Transconjunctival Sutureless Vitrectomy (TSV) Market Perspective (2021-2032)
  2. 3.2 Global Transconjunctival Sutureless Vitrectomy (TSV) Growth Trends by Region
  3. 3.2.1 Global Transconjunctival Sutureless Vitrectomy (TSV) Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Transconjunctival Sutureless Vitrectomy (TSV) Market Size by Region (2021-2026)
  5. 3.2.3 Global Transconjunctival Sutureless Vitrectomy (TSV) Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Transconjunctival Sutureless Vitrectomy (TSV) Revenue by Players
  2. 4.1.1 Global Transconjunctival Sutureless Vitrectomy (TSV) Revenue by Players (2021-2026)
  3. 4.1.2 Global Transconjunctival Sutureless Vitrectomy (TSV) Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Transconjunctival Sutureless Vitrectomy (TSV) Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Transconjunctival Sutureless Vitrectomy (TSV) Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Transconjunctival Sutureless Vitrectomy (TSV) Key Players Headquarters & Area Served
  7. 4.4 Global Transconjunctival Sutureless Vitrectomy (TSV) Players, Product Type & Application
  8. 4.5 Global Transconjunctival Sutureless Vitrectomy (TSV) Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Transconjunctival Sutureless Vitrectomy (TSV) Market CR5 and HHI
  11. 4.6.3 2025 Transconjunctival Sutureless Vitrectomy (TSV) Tier 1, Tier 2, and Tier 3
5 Transconjunctival Sutureless Vitrectomy (TSV) Market Size by Type
  1. 5.1 Global Transconjunctival Sutureless Vitrectomy (TSV) Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Transconjunctival Sutureless Vitrectomy (TSV) Revenue by Type (2021-2032)
  3. 5.3 Global Transconjunctival Sutureless Vitrectomy (TSV) Revenue Market Share by Type (2021-2032)
6 Transconjunctival Sutureless Vitrectomy (TSV) Market Size by Application
  1. 6.1 Global Transconjunctival Sutureless Vitrectomy (TSV) Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Transconjunctival Sutureless Vitrectomy (TSV) Revenue by Application (2021-2032)
  3. 6.3 Global Transconjunctival Sutureless Vitrectomy (TSV) Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Bascom Palmer Eye Institute
  2. 7.1.1 Bascom Palmer Eye Institute Company Information
  3. 7.1.2 Bascom Palmer Eye Institute Business Overview
  4. 7.1.3 Bascom Palmer Eye Institute Transconjunctival Sutureless Vitrectomy (TSV) Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Bascom Palmer Eye Institute Transconjunctival Sutureless Vitrectomy (TSV) Product Portfolio
  6. 7.1.5 Bascom Palmer Eye Institute Recent Developments
  7. 7.2 Moorfields Eye Hospital
  8. 7.2.1 Moorfields Eye Hospital Company Information
  9. 7.2.2 Moorfields Eye Hospital Business Overview
  10. 7.2.3 Moorfields Eye Hospital Transconjunctival Sutureless Vitrectomy (TSV) Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Moorfields Eye Hospital Transconjunctival Sutureless Vitrectomy (TSV) Product Portfolio
  12. 7.2.5 Moorfields Eye Hospital Recent Developments
  13. 7.3 Massachusetts Eye and Ear Infirmary
  14. 7.3.1 Massachusetts Eye and Ear Infirmary Company Information
  15. 7.3.2 Massachusetts Eye and Ear Infirmary Business Overview
  16. 7.3.3 Massachusetts Eye and Ear Infirmary Transconjunctival Sutureless Vitrectomy (TSV) Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Massachusetts Eye and Ear Infirmary Transconjunctival Sutureless Vitrectomy (TSV) Product Portfolio
  18. 7.3.5 Massachusetts Eye and Ear Infirmary Recent Developments
  19. 7.4 Sichuan Provincial People's Hospital
  20. 7.4.1 Sichuan Provincial People's Hospital Company Information
  21. 7.4.2 Sichuan Provincial People's Hospital Business Overview
  22. 7.4.3 Sichuan Provincial People's Hospital Transconjunctival Sutureless Vitrectomy (TSV) Revenue and Gross Margin (2021-2026)
  23. 7.4.4 Sichuan Provincial People's Hospital Transconjunctival Sutureless Vitrectomy (TSV) Product Portfolio
  24. 7.4.5 Sichuan Provincial People's Hospital Recent Developments
  25. 7.5 Tongji Hospital Affiliated to Tongji University
  26. 7.5.1 Tongji Hospital Affiliated to Tongji University Company Information
  27. 7.5.2 Tongji Hospital Affiliated to Tongji University Business Overview
  28. 7.5.3 Tongji Hospital Affiliated to Tongji University Transconjunctival Sutureless Vitrectomy (TSV) Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Tongji Hospital Affiliated to Tongji University Transconjunctival Sutureless Vitrectomy (TSV) Product Portfolio
  30. 7.5.5 Tongji Hospital Affiliated to Tongji University Recent Developments
  31. 7.6 Tianjin Medical University Eye Hospital
  32. 7.6.1 Tianjin Medical University Eye Hospital Company Information
  33. 7.6.2 Tianjin Medical University Eye Hospital Business Overview
  34. 7.6.3 Tianjin Medical University Eye Hospital Transconjunctival Sutureless Vitrectomy (TSV) Revenue and Gross Margin (2021-2026)
  35. 7.6.4 Tianjin Medical University Eye Hospital Transconjunctival Sutureless Vitrectomy (TSV) Product Portfolio
  36. 7.6.5 Tianjin Medical University Eye Hospital Recent Developments
8 North America
  1. 8.1 North America Transconjunctival Sutureless Vitrectomy (TSV) Revenue (2021-2032)
  2. 8.2 North America Transconjunctival Sutureless Vitrectomy (TSV) Revenue by Type (2021-2032)
  3. 8.2.1 North America Transconjunctival Sutureless Vitrectomy (TSV) Revenue by Type (2021-2026)
  4. 8.2.2 North America Transconjunctival Sutureless Vitrectomy (TSV) Revenue by Type (2027-2032)
  5. 8.3 North America Transconjunctival Sutureless Vitrectomy (TSV) Revenue Share by Type (2021-2032)
  6. 8.4 North America Transconjunctival Sutureless Vitrectomy (TSV) Revenue by Application (2021-2032)
  7. 8.4.1 North America Transconjunctival Sutureless Vitrectomy (TSV) Revenue by Application (2021-2026)
  8. 8.4.2 North America Transconjunctival Sutureless Vitrectomy (TSV) Revenue by Application (2027-2032)
  9. 8.5 North America Transconjunctival Sutureless Vitrectomy (TSV) Revenue Share by Application (2021-2032)
  10. 8.6 North America Transconjunctival Sutureless Vitrectomy (TSV) Revenue by Country
  11. 8.6.1 North America Transconjunctival Sutureless Vitrectomy (TSV) Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Transconjunctival Sutureless Vitrectomy (TSV) Revenue by Country (2021-2026)
  13. 8.6.3 North America Transconjunctival Sutureless Vitrectomy (TSV) Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe Transconjunctival Sutureless Vitrectomy (TSV) Revenue (2021-2032)
  2. 9.2 Europe Transconjunctival Sutureless Vitrectomy (TSV) Revenue by Type (2021-2032)
  3. 9.2.1 Europe Transconjunctival Sutureless Vitrectomy (TSV) Revenue by Type (2021-2026)
  4. 9.2.2 Europe Transconjunctival Sutureless Vitrectomy (TSV) Revenue by Type (2027-2032)
  5. 9.3 Europe Transconjunctival Sutureless Vitrectomy (TSV) Revenue Share by Type (2021-2032)
  6. 9.4 Europe Transconjunctival Sutureless Vitrectomy (TSV) Revenue by Application (2021-2032)
  7. 9.4.1 Europe Transconjunctival Sutureless Vitrectomy (TSV) Revenue by Application (2021-2026)
  8. 9.4.2 Europe Transconjunctival Sutureless Vitrectomy (TSV) Revenue by Application (2027-2032)
  9. 9.5 Europe Transconjunctival Sutureless Vitrectomy (TSV) Revenue Share by Application (2021-2032)
  10. 9.6 Europe Transconjunctival Sutureless Vitrectomy (TSV) Revenue by Country
  11. 9.6.1 Europe Transconjunctival Sutureless Vitrectomy (TSV) Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Transconjunctival Sutureless Vitrectomy (TSV) Revenue by Country (2021-2026)
  13. 9.6.3 Europe Transconjunctival Sutureless Vitrectomy (TSV) Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China Transconjunctival Sutureless Vitrectomy (TSV) Revenue (2021-2032)
  2. 10.2 China Transconjunctival Sutureless Vitrectomy (TSV) Revenue by Type (2021-2032)
  3. 10.2.1 China Transconjunctival Sutureless Vitrectomy (TSV) Revenue by Type (2021-2026)
  4. 10.2.2 China Transconjunctival Sutureless Vitrectomy (TSV) Revenue by Type (2027-2032)
  5. 10.3 China Transconjunctival Sutureless Vitrectomy (TSV) Revenue Share by Type (2021-2032)
  6. 10.4 China Transconjunctival Sutureless Vitrectomy (TSV) Revenue by Application (2021-2032)
  7. 10.4.1 China Transconjunctival Sutureless Vitrectomy (TSV) Revenue by Application (2021-2026)
  8. 10.4.2 China Transconjunctival Sutureless Vitrectomy (TSV) Revenue by Application (2027-2032)
  9. 10.5 China Transconjunctival Sutureless Vitrectomy (TSV) Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Transconjunctival Sutureless Vitrectomy (TSV) Revenue (2021-2032)
  2. 11.2 Asia Transconjunctival Sutureless Vitrectomy (TSV) Revenue by Type (2021-2032)
  3. 11.2.1 Asia Transconjunctival Sutureless Vitrectomy (TSV) Revenue by Type (2021-2026)
  4. 11.2.2 Asia Transconjunctival Sutureless Vitrectomy (TSV) Revenue by Type (2027-2032)
  5. 11.3 Asia Transconjunctival Sutureless Vitrectomy (TSV) Revenue Share by Type (2021-2032)
  6. 11.4 Asia Transconjunctival Sutureless Vitrectomy (TSV) Revenue by Application (2021-2032)
  7. 11.4.1 Asia Transconjunctival Sutureless Vitrectomy (TSV) Revenue by Application (2021-2026)
  8. 11.4.2 Asia Transconjunctival Sutureless Vitrectomy (TSV) Revenue by Application (2027-2032)
  9. 11.5 Asia Transconjunctival Sutureless Vitrectomy (TSV) Revenue Share by Application (2021-2032)
  10. 11.6 Asia Transconjunctival Sutureless Vitrectomy (TSV) Revenue by Country
  11. 11.6.1 Asia Transconjunctival Sutureless Vitrectomy (TSV) Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Transconjunctival Sutureless Vitrectomy (TSV) Revenue by Country (2021-2026)
  13. 11.6.3 Asia Transconjunctival Sutureless Vitrectomy (TSV) Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Transconjunctival Sutureless Vitrectomy (TSV) Revenue (2021-2032)
  2. 12.2 SAMEA Transconjunctival Sutureless Vitrectomy (TSV) Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Transconjunctival Sutureless Vitrectomy (TSV) Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Transconjunctival Sutureless Vitrectomy (TSV) Revenue by Type (2027-2032)
  5. 12.3 SAMEA Transconjunctival Sutureless Vitrectomy (TSV) Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Transconjunctival Sutureless Vitrectomy (TSV) Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Transconjunctival Sutureless Vitrectomy (TSV) Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Transconjunctival Sutureless Vitrectomy (TSV) Revenue by Application (2027-2032)
  9. 12.5 SAMEA Transconjunctival Sutureless Vitrectomy (TSV) Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Transconjunctival Sutureless Vitrectomy (TSV) Revenue by Country
  11. 12.6.1 SAMEA Transconjunctival Sutureless Vitrectomy (TSV) Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Transconjunctival Sutureless Vitrectomy (TSV) Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Transconjunctival Sutureless Vitrectomy (TSV) Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst